Advances in medical polyesters for vascular tissue engineering
Source abstract
Abstract
Abstract Blood vessels are highly dynamic and complex structures with a variety of physiological functions, including the transport of oxygen, nutrients, and metabolic wastes. Their normal functioning involves the close and coordinated cooperation of a variety of cells. However, adverse internal and external environmental factors can lead to vascular damage and the induction of various vascular diseases, including atherosclerosis and thrombosis. This can have serious consequences for patients, and there is an urgent need for innovative techniques to repair damaged blood vessels. Polyesters have been extensively researched and used in the treatment of vascular disease and repair of blood vessels due to their excellent mechanical properties, adjustable biodegradation time, and excellent biocompatibility. Given the high complexity of vascular tissues, it is still challenging to optimize the utilization of polyesters for repairing damaged blood vessels. Nevertheless, they have considerable potential for vascular tissue engineering in a range of applications. This summary reviews the physicochemical properties of polyhydroxyalkanoate (PHA), polycaprolactone (PCL), poly-lactic acid (PLA), and poly(lactide-co-glycolide) (PLGA), focusing on their unique applications in vascular tissue engineering. Polyesters can be prepared not only as 3D scaffolds to repair damage as an alternative to vascular grafts, but also in various forms such as microspheres, fibrous membranes, and nanoparticles to deliver drugs or bioactive ingredients to damaged vessels. Finally, it is anticipated that further developments in polyesters will occur in the near future, with the potential to facilitate the wider application of these materials in vascular tissue engineering.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · biodegradable polymer synthesis and properties · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Segal SS. Cell-to-cell communication coordinates blood flow control. Hypertension. 1994;23:1113–20. https://doi.org/10.1161/01.hyp.23.6.1113.10.1161/01.hyp.23.6.1113 ↗
2. Fung YC, Biomechanics: motion, flow, stress, and growth, biomechanics: motion, flow, stress, and growth; 1990.10.1007/978-1-4419-6856-2_1 ↗
3. Barbour JR, Spinale FG, Ikonomidis JS. Proteinase systems and thoracic aortic aneurysm progression. J Surg Res. 2007;139:292–307. https://doi.org/10.1016/j.jss.2006.09.020.10.1016/j.jss.2006.09.020 ↗
4. Hasan A, Memic A, Annabi N, et al. Electrospun scaffolds for tissue engineering of vascular grafts. Acta Biomater. 2014;10:11–25. https://doi.org/10.1016/j.actbio.2013.08.022.10.1016/j.actbio.2013.08.022 ↗
5. Lust ST, Shanahan CM, Shipley RJ, et al. Design considerations for engineering 3D models to study vascular pathologies in vitro. Acta Biomater. 2021;132:114–28. https://doi.org/10.1016/j.actbio.2021.02.031.10.1016/j.actbio.2021.02.031 ↗
6. Ratcliffe A. Tissue engineering of vascular grafts. Matrix Biol. 2000;19:353–7. https://doi.org/10.1016/s0945-053x(00)00080-9.10.1016/s0945-053x(00)00080-9 ↗
7. Chang WG, Niklason LE. A short discourse on vascular tissue engineering. NPJ Regen Med. 2017;2:7. https://doi.org/10.1038/s41536-017-0011-6.10.1038/s41536-017-0011-6 ↗
8. Pober JS, Tellides G. Participation of blood vessel cells in human adaptive immune responses. Trends Immunol. 2012;33:49–57. https://doi.org/10.1016/j.it.2011.09.006.10.1016/j.it.2011.09.006 ↗
9. Li Y, Shi Y, Lu Y, et al. Additive manufacturing of vascular stents. Acta Biomater. 2023;167:16–37. https://doi.org/10.1016/j.actbio.2023.06.014.10.1016/j.actbio.2023.06.014 ↗
10. van Engeland NCA, Pollet A, den Toonder JMJ, et al. A biomimetic microfluidic model to study signalling between endothelial and vascular smooth muscle cells under hemodynamic conditions. Lab Chip. 2018;18:1607–20. https://doi.org/10.1039/c8lc00286j.10.1039/c8lc00286j ↗
11. Hyuk Im S, Hyeok Im D, Jeong Park S, et al. Current status and future direction of metallic and polymeric materials for advanced vascular stents. Prog Mater Sci. 2022;126:100922. https://doi.org/10.1016/j.pmatsci.2022.100922.10.1016/j.pmatsci.2022.100922 ↗
12. Browning MB, Dempsey D, Guiza V, et al. Multilayer vascular grafts based on collagen-mimetic proteins. Acta Biomater. 2011;8:1010–21. https://doi.org/10.1016/j.actbio.2011.11.015.10.1016/j.actbio.2011.11.015 ↗
13. Gong Z, Niklason LE. Blood vessels engineered from human cells. Trends Cardiovasc Med. 2006;16:153–6. https://doi.org/10.1016/S0140-6736(05)66735-9.10.1016/S0140-6736(05)66735-9 ↗
14. Bouten CVC, Dankers PYW, Driessen-Mol A, et al. Substrates for cardiovascular tissue engineering. Adv Drug Deliv Rev. 2011;63(4–5):221–41. https://doi.org/10.1016/j.addr.2011.01.007.10.1016/j.addr.2011.01.007 ↗
15. Chatterjee P, Venkataramani AS, Vijayan A, et al. The effect of state policies on organ donation and transplantation in the United States. Jama Internal Med. 2015;175:1323. https://doi.org/10.1001/jamainternmed.2015.2194.10.1001/jamainternmed.2015.2194 ↗
16. Black AF, Berthod F, L’Heureux N, et al. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J. 1998;12:1331–40. https://doi.org/10.1096/fasebj.12.13.1331.10.1096/fasebj.12.13.1331 ↗
17. Cuono CB, Langdon R, Birchall N, et al. Composite autologous-allogeneic skin replacement: development and clinical application. Plast Reconstr Surg. 1987;80:626–35.10.1097/00006534-198710000-00029 ↗
18. Peck M, Gebhart D, Dusserre N, et al. The evolution of vascular tissue engineering and current state of the art. Cells Tissues Organs. 2011;195:144–58. https://doi.org/10.1159/000331406.10.1159/000331406 ↗
19. Nerem R, Seliktar D. Vascular tissue engineering. Annu Rev Biomed Eng. 2001;3:225–43. https://doi.org/10.1146/annurev.bioeng.3.1.225.10.1146/annurev.bioeng.3.1.225 ↗
20. Darie-Niță RN, Râpă M, Frąckowiak S. Special features of polyester-based materials for medical applications. Polymers (Basel). 2022. https://doi.org/10.3390/polym14050951.10.3390/polym14050951 ↗
21. Fattahi FS, Khoddami A, Avinc O. Nano-fibrous and tubular poly (lactic acid) scaffolds for vascular tissue engineering. Nanomed Res J. 2019;4:141–56. https://doi.org/10.22034/nmrj.2019.03.003.10.22034/nmrj.2019.03.003 ↗
22. Mi CH, Qi XY, Ding YW, et al. Recent advances of medical polyhydroxyalkanoates in musculoskeletal system. Biomater Transl. 2023;4:234–47. https://doi.org/10.12336/biomatertransl.2023.04.004.10.12336/biomatertransl.2023.04.004 ↗
23. Liu J, Zhou Z, Li H, et al. Current status and challenges in the application of microbial PHA particles. Particuology. 2023;87:286–302. https://doi.org/10.1016/j.partic.2023.08.011.10.1016/j.partic.2023.08.011 ↗
24. Xiang Y, Wang Q-Q, Lan X-Q, et al. Function and treatment strategies of β-hydroxybutyrate in aging. Smart Mater Med. 2023;4:160–72. https://doi.org/10.1016/j.smaim.2022.09.003.10.1016/j.smaim.2022.09.003 ↗
25. Labet M, Thielemans W. Synthesis of polycaprolactone: a review. Chem Soc Rev. 2009;38:3484–504. https://doi.org/10.1039/b820162p.10.1039/b820162p ↗
26. Jung JA, Yoo KH, Han SK, et al. Evaluation of the efficacy of highly hydrophilic polyurethane foam dressing in treating a diabetic foot ulcer. Adv Skin Wound Care. 2016;29:546–55. https://doi.org/10.1097/01.Asw.0000508178.67430.34.10.1097/01.Asw.0000508178.67430.34 ↗
27. Danhier F, Ansorena E, Silva JM, et al. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161:505–22. https://doi.org/10.1016/j.jconrel.2012.01.043.10.1016/j.jconrel.2012.01.043 ↗
28. Kohli N, Sharma V, Brown SJ, et al. In Biomaterials for skin repair and regeneration, Elsevier, 2019, pp. 125–149.10.1016/B978-0-08-102546-8.00005-4 ↗
29. Washington MA, Swiner DJ, Bell KR, et al. The impact of monomer sequence and stereochemistry on the swelling and erosion of biodegradable poly(lactic-co-glycolic acid) matrices. Biomaterials. 2017;117:66. https://doi.org/10.1016/j.biomaterials.2016.11.037.10.1016/j.biomaterials.2016.11.037 ↗
30. Chang R, Zhao D, Zhang C, et al. Nanocomposite multifunctional hyaluronic acid hydrogel with photothermal antibacterial and antioxidant properties for infected wound healing. Int J Biol Macromol. 2023;226:870–84. https://doi.org/10.1016/j.ijbiomac.2022.12.116.10.1016/j.ijbiomac.2022.12.116 ↗
31. Kumari A, Raina N, Wahi A, et al. Wound-healing effects of curcumin and its nanoformulations: a comprehensive review. Pharmaceutics. 2022;14:2288. https://doi.org/10.3390/pharmaceutics14112288.10.3390/pharmaceutics14112288 ↗
32. Agarwal Y, Rajinikanth PS, Ranjan S, Tiwari U, Balasubramnaiam J, Pandey P, Arya DK, Anand S, Deepak P. Curcumin loaded polycaprolactone-/polyvinyl alcohol-silk fibroin based electrospun nanofibrous mat for rapid healing of diabetic wound: an in-vitro and in-vivo studies. Int J Biol Macromol: Struct Funct Interact. 2021;176:376–86. https://doi.org/10.1016/j.ijbiomac.2021.02.025.10.1016/j.ijbiomac.2021.02.025 ↗
33. Wei DX, Dao JW, Chen GQ. A micro-ark for cells: highly open porous polyhydroxyalkanoate microspheres as injectable scaffolds for tissue regeneration. Adv Mater. 2018;30:e1802273. https://doi.org/10.1002/adma.201802273.10.1002/adma.201802273 ↗
34. Meng C, Zhao J, Yin Y, et al. Preparation and characterization of PLA film/3D Printing composite scaffold for tissue engineering application. Fibers Polym. 2020;21:709–16. https://doi.org/10.1007/s12221-020-9305-1.10.1007/s12221-020-9305-1 ↗
35. Rahman M, Peng XL, Zhao XH, et al. 3D bioactive cell-free-scaffolds for in-vitro/in-vivo capture and directed osteoinduction of stem cells for bone tissue regeneration. Bioact Mater. 2021. https://doi.org/10.1016/j.bioactmat.2021.01.013.10.1016/j.bioactmat.2021.01.013 ↗
36. Wei D, Qiao R, Dao J, et al. Soybean lecithin-mediated nanoporous PLGA microspheres with highly entrapped and controlled released BMP-2 as a stem cell platform. Small. 2018. https://doi.org/10.1002/smll.201800063.10.1002/smll.201800063 ↗
37. Wei DX, Dao JW, Liu HW, et al. Suspended polyhydroxyalkanoate microspheres as 3D carriers for mammalian cell growth. Artif Cells Nanomed Biotechnol. 2018. https://doi.org/10.1080/21691401.2018.1459635.10.1080/21691401.2018.1459635 ↗
38. Wang B, Wu J-f, Xiao D, et al. 3-hydroxybutyrate in the brain: biosynthesis, function, and disease therapy. Brain-X. 2023. https://doi.org/10.1002/brx2.6.10.1002/brx2.6 ↗
39. Zhao XH, Peng XL, Gong HL, et al. Osteogenic differentiation system based on biopolymer nanoparticles for stem cells in simulated microgravity. Biomed Mater. 2021. https://doi.org/10.1088/1748-605X/abe9d1.10.1088/1748-605X/abe9d1 ↗
40. Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14:1–16. https://doi.org/10.1146/annurev-bioeng-071811-150124.10.1146/annurev-bioeng-071811-150124 ↗
41. Gratton SE, Ropp PA, Pohlhaus PD, et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A. 2008;105:11613–8. https://doi.org/10.1073/pnas.0801763105.10.1073/pnas.0801763105 ↗
42. Banerjee A, Qi J, Gogoi R, et al. Role of nanoparticle size, shape and surface chemistry in oral drug delivery. J Control Release. 2016;238:176–85. https://doi.org/10.1016/j.jconrel.2016.07.051.10.1016/j.jconrel.2016.07.051 ↗
43. Xu N, Peng XL, Li HR, et al. Marine-derived collagen as biomaterials for human health. Front Nutr. 2021;8:702108. https://doi.org/10.3389/fnut.2021.702108.10.3389/fnut.2021.702108 ↗
44. Wei D, Zhang X (2022) Biosynthesis, bioactivity, biotoxicity and applications of antimicrobial peptides for human health. Biosaf Health 4(2):118-134. https://doi.org/10.1016/j.bsheal.2022.02.00310.1016/j.bsheal.2022.02.003 ↗
45. Pearce AK, O’Reilly RK. Polymers for biomedical applications: the importance of hydrophobicity in directing biological interactions and application efficacy. Biomacromol. 2021;22:4459–69. https://doi.org/10.1021/acs.biomac.1c00434.10.1021/acs.biomac.1c00434 ↗
46. Bugnicourt E, Cinelli P, Lazzeri A, et al. Polyhydroxyalkanoate (PHA): review of synthesis, characteristics, processing and potential applications in packaging. Express Polym Lett. 2014;8:791–808. https://doi.org/10.3144/expresspolymlett.2014.82.10.3144/expresspolymlett.2014.82 ↗
47. Chen G-Q. A microbial polyhydroxyalkanoates (PHA) based bio-and materials industry. Chem Soc Rev. 2009;38:2434–46. https://doi.org/10.1039/b812677c.10.1039/b812677c ↗
48. Zhang S, Wang ZH, Chen GQ. Microbial polyhydroxyalkanote synthesis repression protein PhaR as an affinity tag for recombinant protein purification. Microb Cell Fact. 2010;9:28. https://doi.org/10.1186/1475-2859-9-28.10.1186/1475-2859-9-28 ↗
49. Sequeira RA, Dubey S, Pereira MM, et al. Neoteric solvent systems as sustainable media for dissolution and film preparation of poly-[(R)-3-hydroxybutyrate]. ACS Sustain Chem Eng. 2020;8:12005–13. https://doi.org/10.1021/acssuschemeng.0c02684.10.1021/acssuschemeng.0c02684 ↗
50. Zhao W, Chen G-Q. Production and characterization of terpolyester poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) by recombinant Aeromonas hydrophila 4AK4 harboring genes phaAB. Process Biochem. 2007;42:1342–7. https://doi.org/10.1016/j.procbio.2007.07.006.10.1016/j.procbio.2007.07.006 ↗
51. Porter M, Yu J. Crystallization kinetics of poly(3-hydroxybutyrate) granules in different environmental conditions. J Biomater Nanobiotechnol. 2011;2:301. https://doi.org/10.4236/jbnb.2011.23037.10.4236/jbnb.2011.23037 ↗
52. Yu H-Y, Qin Z-Y, Wang L-F, et al. Crystallization behavior and hydrophobic properties of biodegradable ethyl cellulose-g-poly(3-hydroxybutyrate-co-3-hydroxyvalerate): the influence of the side-chain length and grafting density. Carbohydr Polym. 2012;87:2447–54. https://doi.org/10.1016/j.carbpol.2011.11.022.10.1016/j.carbpol.2011.11.022 ↗
53. Lorenzini C, Renard E, Bensemhoun J, et al. High glass transition temperature bio-based copolyesters from poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and isosorbide. React Funct Polym. 2013;73:1656–61. https://doi.org/10.1016/j.reactfunctpolym.2013.10.002.10.1016/j.reactfunctpolym.2013.10.002 ↗
54. Bianco A, Calderone M, Cacciotti I. Electrospun PHBV/PEO co-solution blends: microstructure, thermal and mechanical properties. Mater Sci Eng: C. 2013;33:1067–77. https://doi.org/10.1016/j.msec.2012.11.030.10.1016/j.msec.2012.11.030 ↗
55. Wang Y-Y, Lü L-X, Shi J-C, et al. Introducing RGD peptides on PHBV films through PEG-Containing cross-linkers to improve the biocompatibility. Biomacromol. 2011;12:551–9. https://doi.org/10.1021/bm100886w.10.1021/bm100886w ↗
56. Cheng M-L, Chen P-Y, Lan C-H, et al. Structure, mechanical properties and degradation behaviors of the electrospun fibrous blends of PHBHHx/PDLLA. Polymer. 2011;52:1391–401. https://doi.org/10.1016/j.polymer.2011.01.039.10.1016/j.polymer.2011.01.039 ↗
57. Xie WP, Chen G-Q. Production and characterization of terpolyester poly(3-hydroxybutyrate-co-4-hydroxybutyrate-co-3-hydroxyhexanoate) by recombinant Aeromonas hydrophila 4AK4 harboring genes phaPCJ. Biochem Eng J. 2008;38:384–9. https://doi.org/10.1016/j.bej.2007.08.002.10.1016/j.bej.2007.08.002 ↗
58. Qu XH, Wu Q, Zhang KY, et al. In vivo studies of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) based polymers: biodegradation and tissue reactions. Biomaterials. 2006;27:3540–8. https://doi.org/10.1016/j.biomaterials.2006.02.015.10.1016/j.biomaterials.2006.02.015 ↗
59. Yang M, Zhu S, Chen Y, et al. Studies on bone marrow stromal cells affinity of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate). Biomaterials. 2004;25:1365–73. https://doi.org/10.1016/j.biomaterials.2003.08.018.10.1016/j.biomaterials.2003.08.018 ↗
60. Sun XM, Zhong LH, Lan XP, et al. The compatibility of poly(3-hydroxybutyrate-co-4-hydroxybutyrate) and thermoplastic polyurethane blends. Adva Mater Res. 2013;815:552–7. https://doi.org/10.4028/www.scientific.net/AMR.815.552.10.4028/www.scientific.net/AMR.815.552 ↗
61. Yu Y, Li Y, Han C, et al. Enhancement of the properties of biosourced poly(3-hydroxybutyrate-co-4-hydroxybutyrate) by the incorporation of natural orotic acid. Int J Biol Macromol. 2019;136:764–73. https://doi.org/10.1016/j.ijbiomac.2019.06.056.10.1016/j.ijbiomac.2019.06.056 ↗
62. Lan X, Liu Y, Wang Y, et al. Coaxial electrospun PVA/PCL nanofibers with dual release of tea polyphenols and ε-poly (L-lysine) as antioxidant and antibacterial wound dressing materials. Int J Pharm. 2021;601:120525. https://doi.org/10.1016/j.ijpharm.2021.120525.10.1016/j.ijpharm.2021.120525 ↗
63. Ye H-M, Wang Z, Wang H-H, et al. Different thermal behaviors of microbial polyesters poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate). Polymer. 2010;51:6037–46. https://doi.org/10.1016/j.polymer.2010.10.030.10.1016/j.polymer.2010.10.030 ↗
64. Bhatia SK, Gurav R, Choi T-R, et al. Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) production from engineered Ralstonia eutropha using synthetic and anaerobically digested food waste derived volatile fatty acids. Int J Biol Macromol. 2019;133:1–10. https://doi.org/10.1016/j.ijbiomac.2019.04.083.10.1016/j.ijbiomac.2019.04.083 ↗
65. Ranakoti L, Gangil B, Mishra SK, et al. Critical review on polylactic acid: properties, structure, processing, biocomposites, and nanocomposites. Materials. 2022;15:4312. https://doi.org/10.3390/ma15124312.10.3390/ma15124312 ↗
66. Oh SH, Park IK, Kim JM, et al. In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method. Biomaterials. 2007;28:1664–71. https://doi.org/10.1016/j.biomaterials.2006.11.024.10.1016/j.biomaterials.2006.11.024 ↗
67. Schmitt PR, Dwyer KD, Coulombe KL. Current applications of polycaprolactone as a scaffold material for heart regeneration. ACS Appl Bio Mater. 2022;5:2461–80. https://doi.org/10.1021/acsabm.2c00174.10.1021/acsabm.2c00174 ↗
68. Zhao W, Li J, Jin K, et al. Fabrication of functional PLGA-based electrospun scaffolds and their applications in biomedical engineering. Mater Sci Eng C Mater Biol Appl. 2016;59:1181–94. https://doi.org/10.1016/j.msec.2015.11.026.10.1016/j.msec.2015.11.026 ↗
69. Rocha CV, Gonçalves V, da Silva MC, et al. PLGA-based composites for various biomedical applications. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms23042034.10.3390/ijms23042034 ↗
70. Ren Z-W, Wang Z-Y, Ding Y-W et al (2023) Polyhydroxyalkanoates: the natural biopolyester for future medical innovations. Biomater Sci 11(18):6013–6034. https://doi.org/10.1039/D3BM01043K10.1039/D3BM01043K ↗
71. Elmowafy E, Abdal-Hay A, Skouras A, et al. Polyhydroxyalkanoate (PHA): applications in drug delivery and tissue engineering. Expert Rev Med Dev. 2019;16:467–82. https://doi.org/10.1080/17434440.2019.1615439.10.1080/17434440.2019.1615439 ↗
72. Rodriguez-Contreras A. Recent advances in the use of polyhydroyalkanoates in biomedicine. Bioengineering (Basel). 2019;6:82. https://doi.org/10.3390/bioengineering6030082.10.3390/bioengineering6030082 ↗
73. Dwivedi R, Pandey R, Kumar S, et al. Poly hydroxyalkanoates (PHA): role in bone scaffolds. J Oral Biol Craniofac Res. 2020;10:389–92. https://doi.org/10.1016/j.jobcr.2019.10.004.10.1016/j.jobcr.2019.10.004 ↗
74. Miu DM, Eremia MC, Moscovici M. Polyhydroxyalkanoates (PHAs) as biomaterials in tissue engineering: production, isolation, characterization. Materials (Basel). 2022;15:1410. https://doi.org/10.3390/ma15041410.10.3390/ma15041410 ↗
75. Guo W, Yang K, Qin X, et al. Polyhydroxyalkanoates in tissue repair and regeneration. Eng Regen. 2022;3:24–40. https://doi.org/10.1016/j.engreg.2022.01.003.10.1016/j.engreg.2022.01.003 ↗
76. Ang SL, Shaharuddin B, Chuah JA, et al. Electrospun poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)/silk fibroin film is a promising scaffold for bone tissue engineering. Int J Biol Macromol. 2020;145:173–88. https://doi.org/10.1016/j.ijbiomac.2019.12.149.10.1016/j.ijbiomac.2019.12.149 ↗
77. Moraes RP, Smeets NMB, McKenzie NT, et al. Reactive mcl-PHA: a sustainable alternative for innovative hybrid materials. Macromol Mater Eng. 2013;298:1004–15. https://doi.org/10.1002/mame.201200295.10.1002/mame.201200295 ↗
78. Ding Y-W, Li Y, Zhang Z-W et al (2024) Hydrogel forming microneedles loaded with VEGF and Ritlecitinib/polyhydroxyalkanoates nanoparticles for mini-invasive androgenetic alopecia treatment. Bioact Mater 38:95–108. https://doi.org/10.1016/j.bioactmat.2024.04.02010.1016/j.bioactmat.2024.04.020 ↗
79. Lim J, You M, Li J, et al. Emerging bone tissue engineering via polyhydroxyalkanoate (PHA)-based scaffolds. Mater Sci Eng, C. 2017;79:917–29. https://doi.org/10.1016/j.jobcr.2019.10.004.10.1016/j.jobcr.2019.10.004 ↗
80. Peng XL, Cheng JS, Gong HL, et al. Advances in the design and development of SARS-CoV-2 vaccines. Mil Med Res. 2021;8:67. https://doi.org/10.1186/s40779-021-00360-1.10.1186/s40779-021-00360-1 ↗
81. Hu J, Wang M, Xiao X, et al. A novel long-acting azathioprine polyhydroxyalkanoate nanoparticle enhances treatment efficacy for systemic lupus erythematosus with reduced side effects. Nanoscale. 2020;12:10799–808. https://doi.org/10.1039/d0nr01308k.10.1039/d0nr01308k ↗
82. Chen GQ, Wu Q. The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials. 2005;26:6565–78. https://doi.org/10.1016/j.biomaterials.2005.04.036.10.1016/j.biomaterials.2005.04.036 ↗
83. Pulingam T, Appaturi JN, Parumasivam T, et al. Biomedical applications of polyhydroxyalkanoate in tissue engineering. Polymers (Basel). 2022;14:2141. https://doi.org/10.3390/polym14112141.10.3390/polym14112141 ↗
84. Volova TG, Shishatskaya EI, Nikolaeva ED, et al. In vivo study of 2D PHA matrices of different chemical compositions: tissue reactions and biodegradations. Mater Sci Technol. 2014;30:549–57. https://doi.org/10.1179/1743284713Y.0000000470.10.1179/1743284713Y.0000000470 ↗
85. Nelson T, Kaufman E, Kline J, et al. The extraneural distribution of gamma-hydroxybutyrate. J Neurochem. 1981;37:1345–8. https://doi.org/10.1111/j.1471-4159.1981.tb04689.x.10.1111/j.1471-4159.1981.tb04689.x ↗
86. Yamashita K, Yamada M, Numata K, et al. Nonspecific hydrophobic interactions of a repressor protein, PhaR, with poly [(R)-3-hydroxybutyrate] film studied with a quartz crystal microbalance. Biomacromol. 2006;7:2449–54. https://doi.org/10.1021/bm060442o.10.1021/bm060442o ↗
87. Kouhi M, Prabhakaran MP, Shamanian M, et al. Electrospun PHBV nanofibers containing HA and bredigite nanoparticles: fabrication, characterization and evaluation of mechanical properties and bioactivity. Compos Sci Technol. 2015;121:115–22. https://doi.org/10.1016/j.compscitech.2015.11.006.10.1016/j.compscitech.2015.11.006 ↗
88. Wang XP, Li WF, Zhang H, et al. Effect of sodium benzoate on the crystallization behavior of poly(3-hydroxybutyrate-co-4-hydroxybutyrate). Appl Mech Mater. 2014;665:375–8. https://doi.org/10.4028/www.scientific.net/amm.665.375.10.4028/www.scientific.net/amm.665.375 ↗
89. Li W, Cicek N, Levin DB, et al. Bacteria-triggered release of a potent biocide from core-shell polyhydroxyalkanoate (PHA)-based nanofibers for wound dressing applications. J Biomater Sci Polym Ed. 2020;31:394–406. https://doi.org/10.1002/anie.201307975.10.1002/anie.201307975 ↗
90. Jung H-R, Jeon J-M, Yi D-H, et al. Poly (3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) terpolymer production from volatile fatty acids using engineered Ralstonia eutropha. Int J Biol Macromol. 2019;138:370–8. https://doi.org/10.1016/j.ijbiomac.2019.07.091.10.1016/j.ijbiomac.2019.07.091 ↗
91. Ahmed T, Marcal H, Lawless M, et al. Polyhydroxybutyrate and its copolymer with polyhydroxyvalerate as biomaterials: influence on progression of stem cell cycle. Biomacromol. 2010;11:2707–15. https://doi.org/10.1021/bm1007579.10.1021/bm1007579 ↗
92. Qu XH, Wu Q, Chen GQ. In vitro study on hemocompatibility and cytocompatibility of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate). J Biomater Sci Polym Ed. 2006;17:1107–21. https://doi.org/10.1163/156856206778530704.10.1163/156856206778530704 ↗
93. Sadat F, Fattahi FS. Emerging nanofibrous polycaprolactone vascular grafts in small and large animal models: in vivo and in vitro analyses. Nanochem Res. 2023;8(3):173–80. https://doi.org/10.22036/ncr.2023.03.002.10.22036/ncr.2023.03.002 ↗
94. Mei N, Chen G, Zhou P, et al. Biocompatibility of poly(epsilon-caprolactone) scaffold modified by chitosan: the fibroblasts proliferation in vitro. J Biomater Appl. 2005;19:323–39. https://doi.org/10.1177/0885328205048630.10.1177/0885328205048630 ↗
95. Abedalwafa M, Wang F, Wang L, et al. Biodegradable poly-epsilon-caprolactone (PCL) for tissue engineering applications: a review. Rev Adv Mater Sci. 2013;34:123–40.
96. Dwivedi R, Kumar S, Pandey R, et al. Polycaprolactone as biomaterial for bone scaffolds: review of literature. J Oral Biol Craniof Res. 2020;10:381–8. https://doi.org/10.1016/j.jobcr.2019.10.003.10.1016/j.jobcr.2019.10.003 ↗
97. Serrano MC, Pagani R, Vallet-Regí M, et al. In vitro biocompatibility assessment of poly(epsilon-caprolactone) films using L929 mouse fibroblasts. Biomaterials. 2004;25:5603–11. https://doi.org/10.1016/j.biomaterials.2004.01.037.10.1016/j.biomaterials.2004.01.037 ↗
98. Matumba KI, Mokhena TC, Ojijo V, et al. Morphological characteristics, properties, and applications of polylactide/poly (ε-caprolactone) blends and their composites: a review. Macromol Mater Eng. 2024. https://doi.org/10.1002/mame.202400056.10.1002/mame.202400056 ↗
99. Fattahi FS, Zamani T. Hemocompatibility poly (lactic acid) nanostructures: a bird’s eye view. Nanomed J. 2020;7:263–71. https://doi.org/10.22038/NMJ.2020.07.00002.10.22038/NMJ.2020.07.00002 ↗
100. Farah S, Anderson DG, Langer R. Physical and mechanical properties of PLA, and their functions in widespread applications: a comprehensive review. Adv Drug Deliv Rev. 2016;107:367–92. https://doi.org/10.1016/j.addr.2016.06.012.10.1016/j.addr.2016.06.012 ↗